Literature DB >> 12551719

Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain.

Myoung-Sun Roh1, Ung Gu Kang, Soon Young Shin, Young Han Lee, Hee Yeon Jung, Yong-Sung Juhnn, Yong Sik Kim.   

Abstract

BACKGROUND: Glycogen synthase kinase-3beta (GSK-3beta) plays important roles in intracellular signaling pathways. Phosphorylation at Ser-9 reduces the activity of GSK-3beta, while phosphorylation at Tyr-216 enhances its activity. Mood stabilizing agents increase the phosphorylation of GSK-3beta at Ser-9, and hence inhibit its activity. This property has been considered to be related to the therapeutic action of these drugs. The effect of electroconvulsive shock (ECS), an effective mood stabilizing treatment, on the phosphorylation of GSK-3beta is not known yet.
METHODS: In this study, the effect of ECS on the phosphorylation of GSK-3beta was examined in the rat frontal cortex, hippocampus, and cerebellum by Western blot analysis using antibodies specific for Ser-9 or Tyr-216 phosphorylated GSK-3beta.
RESULTS: In all regions, the phosphorylation of GSK-3beta at Ser-9 was decreased immediately after ECS, but then increased above basal level within 10 min and maintained at an increased level for more than 30 min. Meanwhile, the phosphorylation at Tyr-216 of GSK-3beta did not show any significant changes after ECS.
CONCLUSIONS: These results showed that ECS could induce biphasic changes in the Ser-9 phosphorylation of GSK-3beta in the rat brain, suggesting some similarities, as well as differences, in the actions of mood stabilizers and ECS in the signal transduction mechanisms of the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551719     DOI: 10.1016/s0278-5846(02)00307-x

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  12 in total

Review 1.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

Review 2.  Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Authors:  Richard S Jope; Myoung-Sun Roh
Journal:  Curr Drug Targets       Date:  2006-11       Impact factor: 3.465

3.  Regulation of glycogen synthase kinase-3 during bipolar mania treatment.

Authors:  Xiaohong Li; Min Liu; Zhuoji Cai; Gang Wang; Xiaohua Li
Journal:  Bipolar Disord       Date:  2010-11       Impact factor: 6.744

Review 4.  Convergent Mechanisms Underlying Rapid Antidepressant Action.

Authors:  Panos Zanos; Scott M Thompson; Ronald S Duman; Carlos A Zarate; Todd D Gould
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

Review 5.  Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.

Authors:  M G Soeiro-de-Souza; V V Dias; M L Figueira; O V Forlenza; W F Gattaz; C A Zarate; R Machado-Vieira
Journal:  Acta Psychiatr Scand       Date:  2012-06-08       Impact factor: 6.392

Review 6.  GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.

Authors:  Michael K Rowe; Charlotte Wiest; De-Maw Chuang
Journal:  Neurosci Biobehav Rev       Date:  2007-03-15       Impact factor: 8.989

Review 7.  Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.

Authors:  Mark J Niciu; Dawn F Ionescu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  CNS Spectr       Date:  2013-03-11       Impact factor: 3.790

8.  Individual Differences in Behavioural Despair Predict Brain GSK-3beta Expression in Mice: The Power of a Modified Swim Test.

Authors:  Tatyana Strekalova; Nataliia Markova; Elena Shevtsova; Olga Zubareva; Anastassia Bakhmet; Harry M Steinbusch; Sergey Bachurin; Klaus-Peter Lesch
Journal:  Neural Plast       Date:  2016-07-05       Impact factor: 3.599

9.  Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.

Authors:  Juuso V Leikas; Samuel Kohtala; Wiebke Theilmann; Aaro J Jalkanen; Markus M Forsberg; Tomi Rantamäki
Journal:  J Neurochem       Date:  2017-06-14       Impact factor: 5.372

10.  Interaction between Neuronal Depolarization and MK-801 in SH-SY5Y Cells and the Rat Cortex.

Authors:  Yeni Kim; Miran Seo; Yun-Il Lee; So-Young Kim; Eun-Ah Cho; Se-Hyun Kim; Yong-Min Ahn; Ung-Gu Kang; Yong-Sik Kim; Yong-Sung Juhnn
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.